6Hooker AC, Ten Tije AJ,Cardueei MA, et a l. Population pharmaeokinetic model for doeetaxel in patients with varying degrees of liver function: incorporating eytochrome P450 3A activity measurements [J]. Clin Pharmacol Ther, 2008, 84 ( 1 ) : 111-118.
7Petain A, Kattygnarath D, Azard J, et al. Population pharmacokinetics and pharmacogenetics of imatinib in children and adults [J]. Clin Cancer Res,2008,14(21 ) :7102-7109.
8Saito Y,Katori N, Soyama A, et al. CYP2C8 haplotype structures and their influence on pharmacokinetics of paclitaxel in a Japanese population [J]. Pharmacogenet Genomics, 2007, 17 (7):461-471.
9King CD, Riso GR, Green MD, et al. UDP-glucuronosyltransferases[J]. Curr Drug Metal,2000,1 : 143-161.
10Thompson PA, Gupta M, Rosner Gl, et al. Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children's oncology group[J]. Cancer Chemother Pharmacol, 2008,62 ( 6 ) : 1027-1037.
